Interpace Diagnostics Announces New Coverage by Blue Cross Blue Shield for Thyroid Testing

The Federal Employee Health Benefit BCBS Program Adds Approximately 5.3 Million Covered Lives PARSIPPANY, NJ, Nov. 07, 2018 (GLOBE NEWSWIRE) — Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that the Blue Cross Blue Shield (“BCBS”) Federal Employee Health Benefit Program (“FEHBP”) has extended coverage of ThyGeNEXT™ and ThyraMIR® to its 5.3 million covered lives …

Interpace Diagnostics Announces New Coverage by Blue Cross Blue Shield for Thyroid Testing Read More »